|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 4/30/10 Neogenix Oncology Inc 10-12G 32:4.4M RR Donnelley/FA |
Document/Exhibit Description Pages Size
1: 10-12G Form 10 HTML 860K
2: EX-3.1 Amended and Restated Articles of Incorporation HTML 53K
3: EX-3.2 Second Amended and Restated Bylaws HTML 98K
4: EX-4.1 Specimen Common Stock Certificate HTML 11K
5: EX-10.1 Employment Agreement Dated May 5, 2009 HTML 68K
14: EX-10.10 Form of Incentive Stock Option Agreement HTML 84K
15: EX-10.11 Lease by and Between the Registrant & Affiliated HTML 140K
Developers, Dated 03/17/2005
16: EX-10.12 First Modification of Lease, Dated 07/18/2008 HTML 36K
17: EX-10.13 Second Modification of Lease, Dated 01/22/2009 HTML 26K
18: EX-10.14 Third Modification of Lease, Dated 10/27/2009 HTML 52K
19: EX-10.15 Lease and License Agreement, Dated 04/28/2004 HTML 50K
20: EX-10.16 Amendment No. 1 to Lease and License Agreement, HTML 23K
Dated 05/28/2004
21: EX-10.17 Amendment No. 2 to Lease and License Agreement, HTML 23K
Dated 06/17/2005
22: EX-10.18 Amendment No. 3 to Lease and License Agreement , HTML 20K
Dated 07/02/2006
23: EX-10.19 Amendment No. 4 to Lease and License Agreement , HTML 21K
Dated 05/11/2007
6: EX-10.2 Amendment to Employment Agreement, Dated HTML 22K
02/19/2010
24: EX-10.20 Amendment No. 5 to Lease and License Agreement, HTML 23K
Dated 01/25/2008
25: EX-10.21 Amendment No. 6 to Lease and License Agreement, HTML 23K
Dated 03/21/2008
26: EX-10.22 Amendment No. 7 to Lease and License Agreement, HTML 22K
Dated 08/11/2008
27: EX-10.23 Amendment No. 9 to Lease and License Agreement, HTML 19K
Dated 04/30/2009
28: EX-10.24 Amendment No. 10 to Lease and License Agreement, HTML 22K
Dated 08/20/2009
29: EX-10.25 Amendment No. 10 (#2) to Lease and License HTML 21K
Agreement, Dated 09/29/2009
30: EX-10.26 Amendment No. 11 to Lease and License Agreement, HTML 22K
Dated 01/19/2010
31: EX-10.27 Amendment No. 12 to Lease and License Agreement, HTML 21K
Dated 02/12/2010
32: EX-10.28 Service Agreement HTML 361K
7: EX-10.3 Employment Agreement Dated May 5, 2009 HTML 69K
8: EX-10.4 Amendment to Employment Agreement, Dated HTML 22K
02/19/2010
9: EX-10.5 Employment Agreement Dated May 5, 2009 HTML 67K
10: EX-10.6 Amendment to Employment Agreement, Dated HTML 22K
02/19/2010
11: EX-10.7 2005 Employee, Director and Consultant Stock HTML 77K
Option Plan, as Amended
12: EX-10.8 2005 Amended and Restated Stock Option Plan HTML 90K
13: EX-10.9 Form of Non-Qualified Stock Option Agreement HTML 67K
| Amendment No. 10 (#2) to Lease and License Agreement, dated 09/29/2009 |
Exhibit 10.25
MARYLAND TECHNOLOGY DEVELOPMENT CENTER
LICENSE AGREEMENT
AMENDMENT 10
This addendum is made this 29th day of September, 2009, by and between MEDCO and Neogenix Oncology, Inc. ("Licensee").
WHEREAS, MEDCO and Licensee have entered into a License Agreement dated April 28, 2004;
WHEREAS, Licensee currently occupies Labs #211, #222 and #226, and offices #261, #262, #267 and #317 in the Maryland Technology Development Center in Montgomery County, Maryland (the "Original Premises");
WHEREAS Licensee wishes to expand its office space within the Maryland Technology Development Center and MEDCO is willing to provide for such expansion based on the terms provided for below;
NOW, THEREFORE, in consideration of the mutual covenants and agreements stated herein, the parties agree as follows:
| 1. | Effective October 15, 2009, Licensee shall occupy office #260 (the "Expansion Premises"). |
| 2. | The Monthly Payment, for the Expansion Premises, provided herein shall be as follows: |
| From October 15, 2009 to October 31, 2009 |
$ | 178 | |
| From November 1, 2009 to April 30, 2010 |
$ | 345 |
| 3. | The aggregate Monthly Payment, to include the Monthly Payment for the Original Premises and the Reduction Premises provided for herein shall be as follows: |
| From November 1, 2009 to April 30, 2010 |
$ | 14,499 | |
| Renewal Term (if granted by MEDCO) From May 1, 2010 to April 30, 2011 |
$ | 14,499 | |
| 4. | All other provisions of the original License Agreement shall apply to this Amendment |
This Amendment may be signed in counterparts.
| FOR: | Maryland Economic Development Corporation |
FOR: | Neogenix Oncology, Inc. | |||||
| BY: |
|
BY: |
| |||||
| Scheer Partners, Inc. Center Manager |
||||||||
| Date: | 9/29/09 | Date: | 9.28.09 | |||||
| BY: | ||||||||
| Executive Director, MEDCO |
||||||||
| Date: | 10/15/09 | |||||||
| This ‘10-12G’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| 4/30/11 | None on these Dates | |||
| 5/1/10 | ||||
| Filed on: | 4/30/10 | |||
| 11/1/09 | ||||
| 10/31/09 | ||||
| 10/15/09 | ||||
| 4/28/04 | ||||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/03/10 SEC UPLOAD¶ 10/20/17 1:49K Neogenix Oncology Inc. 7/07/10 SEC UPLOAD¶ 10/20/17 1:61K Neogenix Oncology Inc. 6/24/10 SEC UPLOAD¶ 10/20/17 1:95K Neogenix Oncology Inc. 5/24/10 SEC UPLOAD¶ 10/20/17 1:125K Neogenix Oncology Inc. |
